FDA Approved: CARBIDOPA, LEVODOPA, AND ENTACAPONE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for the Parkinson's disease combination therapy Carbidopa/Levodopa/Entacapone manufactured by Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Stalevo (levodopa;carbidopa;entacapone)

Snippet

SUPPL AP for CARBIDOPA, LEVODOPA, AND ENTACAPONE (CARBIDOPA, LEVODOPA, AND ENTACAPONE)